Antibody Citations
OriGene products have been used extensively by scientists worldwide to improve their research efficiency. For your reference, we have collected a representation of citations for selected OriGene products and posted them at this site.
Search citations by gene symbols or target names
Here are some of the recent papers making use of OriGene products by fellow researchers.
| Target | Research Paper | Journal | Product | SKU |
|---|---|---|---|---|
| Secondary Antibody | Stiffness-Controlled Thermoresponsive Hydrogels for Cell Harvesting with Sustained Mechanical Memory | Adv Healthc Mater, 2017 Jan | Antibody | TA130004 |
| Secondary Antibody | Stiffness-Controlled Thermoresponsive Hydrogels for Cell Harvesting with Sustained Mechanical Memory | Adv Healthc Mater, 2017 Jan | Antibody | TA130015 |
| Secondary Antibody | Stiffness-Controlled Thermoresponsive Hydrogels for Cell Harvesting with Sustained Mechanical Memory | Adv Healthc Mater, 2017 Jan | Antibody | TA130025 |
| Secondary antibody | MBD3 inhibits formation of liver cancer stem cells | Oncotarget, 2017 Jan | Antibody | TA130013 |
| Secondary antibody | MBD3 inhibits formation of liver cancer stem cells | Oncotarget, 2017 Jan | Antibody | TA130021 |
| Secondary Antibody | Effects of adenosine stimulation on the mRNA expression of CLCNKB in the basolateral medullary thick ascending limb of the rat kidney | Mol Med Rep, 2016 Nov | Antibody | TA130023 |
| Secondary Antibody | Increased serum leptin level in overweight patients with colon carcinoma: A cross-sectional and prospective study | Mol Clin Oncol., 2016 Nov | Antibody | AP21490BT-N |
| Secondary Antibody | Use of 5-Fluorouracil Loaded Micelles and Cisplatin in Thermosensitive Chitosan Hydrogel as an Efficient Therapy against Colorectal Peritoneal Carcinomatosis | Macromol Biosci, 2016 Oct | Antibody | TA130023 |
| Secondary Antibody | PCSK9 modulates the secretion but not the cellular uptake of Lipoprotein (a) ex vivo: an effect blunted by alirocumab | JACC: Basic to Translational Science, 2016 Oct | Antibody | TA130023 |
| Secondary Antibody | PCSK9 Modulates the Secretion But Not the Cellular Uptake of Lipoprotein(a) ExVivo: An Effect Blunted by Alirocumab | JACC Basic to Translational science, 2016 Oct | Antibody | TA130023 |
| Secondary Antibody | Perturbed Mucosal Immunity and Dysbiosis Accompany Clinical Disease in a Rat Model of Spondyloarthritis | Arthritis Rheumatol., 2016 Sep | Antibody | SM1027P |
| Secondary antibody | Cytoskeleton-centric protein transportation by exosomes transforms tumor-favorable macrophages | Oncotarget, 2016 Sep | Antibody | TA130021 |
| Secondary antibody | Construction of Functional Targeting Daunorubicin Liposomes Used for Eliminating Brain Glioma and Glioma Stem Cells | Journal of Biomedical Nanotechnology, 2016 Jul | Antibody | TA130021 |
| Secondary antibody | Formononetin exhibits anti-hyperglycemic activity in alloxan-induced type 1 diabetic mice | Exp. Biol. Med. (Maywood) 2016, 2016 Jul | Antibody | TA130023 |
| Secondary Antibody | Monitoring carbamazepine in surface and wastewaters by an immunoassay based on a monoclonal antibody | Anal Bioanal Chem, 2016 Jul | Antibody | R1612P |
| Secondary Antibody | Disease-specific cross-reactivity between mimicking peptides of heat shock protein of Mycobacterium gordonae and dominant epitope of E2 subunit of pyruvate dehydrogenase is common in Spanish but not British patients with primary biliary cirrhosi | J. Autoimmun., 2016 Jun | Antibody | AM01158AP-N |
| Secondary Antibody | Disease-specific cross-reactivity between mimicking peptides of heat shock protein of Mycobacterium gordonae and dominant epitope of E2 subunit of pyruvate dehydrogenase is common in Spanish but not British patients with primary biliary cirrhosi | J. Autoimmun., 2016 Jun | Antibody | AM01158HR-N |
| Secondary Antibody | Metabolic Suppression of a Drug-Resistant Subpopulation in Cancer Spheroid Cells | J. Cell. Biochem., 2016 Jan | Antibody | R1253F |
| Secondary Antibody | IgG2 inhibits HIV-1 internalization by monocytes, and IgG subclass binding is affected by gp120 glycosylation | AIDS, 2015 Nov | Antibody | AM01158AP-N |
| Secondary Antibody | IgG2 inhibits HIV-1 internalization by monocytes, and IgG subclass binding is affected by gp120 glycosylation | AIDS, 2015 Nov | Antibody | AM01158HR-N |
| Secondary Antibody | Folic acid deficiency induces premature hearing loss through mechanisms involving cochlear oxidative stress and impairment of homocysteine metabolism | FASEB J., 2015 Nov | Antibody | R1300B |
| Secondary Antibody | Oral rice-based vaccine induces passive and active immunity against enterotoxigenic E. coli-mediated diarrhea in pigs | Vaccine, 2015 Aug | Antibody | SP2016HRP |
| Secondary Antibody | Synthetic Long Peptide Influenza Vaccine Containing Conserved T and B Cell Epitopes Reduces Viral Load in Lungs of Mice and Ferrets | PLoS One., 2015 Jun | Antibody | R1313P |
| Secondary Antibody | A classification of Hashimoto's thyroiditis based on immunohistochemistry for IgG4 and IgG | Thyroid, 2014 Nov | Antibody | AM01158AP-N |
| Secondary Antibody | A classification of Hashimoto's thyroiditis based on immunohistochemistry for IgG4 and IgG | Thyroid, 2014 Nov | Antibody | AM01158HR-N |
| Secondary Antibody | IgE recognition of chimeric isoforms of the honeybee (Apis mellifera) venom allergen Api m 10 evaluated by protein array technology | Mol. Immunol., 2014 Oct | Antibody | AP05393HR-N |
| Secondary Antibody | Rituximab impairs immunoglobulin (Ig)M and IgG (subclass) responses after influenza vaccination in rheumatoid arthritis patients | Clin. Exp. Immunol., 2014 Oct | Antibody | AM01158AP-N |
| Secondary Antibody | Rituximab impairs immunoglobulin (Ig)M and IgG (subclass) responses after influenza vaccination in rheumatoid arthritis patients | Clin. Exp. Immunol., 2014 Oct | Antibody | AM01158HR-N |
| Secondary Antibody | Donor-specific HLA antibodies: evaluating the risk for graft loss in renal transplant recipients with isotype switch from complement fixing IgG1/IgG3 to noncomplement fixing IgG2/IgG4 anti-HLA alloantibodies | Transpl. Int., 2014 Oct | Antibody | AM01158AP-N |
| Secondary Antibody | Donor-specific HLA antibodies: evaluating the risk for graft loss in renal transplant recipients with isotype switch from complement fixing IgG1/IgG3 to noncomplement fixing IgG2/IgG4 anti-HLA alloantibodies | Transpl. Int., 2014 Oct | Antibody | AM01158HR-N |
| Secondary Antibody | The clinical and immunological features of patients with combined anti-glomerular basement membrane disease and membranous nephropathy | Kidney Int., 2014 Sep | Antibody | AM01158AP-N |
| Secondary Antibody | The clinical and immunological features of patients with combined anti-glomerular basement membrane disease and membranous nephropathy | Kidney Int., 2014 Sep | Antibody | AM01158HR-N |
| Secondary Antibody | Determinants of C1q binding in the single antigen bead assay | Transplantation, 2014 Aug | Antibody | AM01158HR-N |
| Secondary Antibody | Determinants of C1q binding in the single antigen bead assay | Transplantation, 2014 Aug | Antibody | AM01158AP-N |
| Secondary Antibody | Determinants of C1q binding in the single antigen bead assay | Transplantation., 2014 Aug | Antibody | SM2069AP |
| Secondary Antibody | Pretransplant IgG reactivity to apoptotic cells correlates with late kidney allograft loss | Am. J. Transplant., 2014 Jun | Antibody | AM01158AP-N |
| Secondary Antibody | Pretransplant IgG reactivity to apoptotic cells correlates with late kidney allograft loss | Am. J. Transplant., 2014 Jun | Antibody | AM01158HR-N |
| Secondary Antibody | Pretransplant IgG reactivity to apoptotic cells correlates with late kidney allograft loss | Am J Transplant., 2014 Jun | Antibody | SM2069AP |
| Secondary Antibody | Donor-specific HLA antibodies: evaluating the risk for graft loss in renal transplant recipients with isotype switch from complement fixing IgG1/IgG3 to noncomplement fixing IgG2/IgG4 anti-HLA alloantibodies | Transpl Int., 2013 Oct | Antibody | SM2069AP |
| Secondary Antibody | Significant IgG subclass heterogeneity in HLA-specific antibodies: Implications for pathogenicity, prognosis, and the rejection response | Hum Immunol., 2013 Jan | Antibody | SM2069AP |
| Secondary Antibody | Pathogen-triggered activation of plasmacytoid dendritic cells induces IL-10-producing B cells in response to Staphylococcus aureus | J. Immunol., 2013 Jan | Antibody | AM01158AP-N |
| Secondary Antibody | Pathogen-triggered activation of plasmacytoid dendritic cells induces IL-10-producing B cells in response to Staphylococcus aureus | J. Immunol., 2013 Jan | Antibody | AM01158HR-N |
| Secondary Antibody | Pathogen-triggered activation of plasmacytoid dendritic cells induces IL-10-producing B cells in response to Staphylococcus aureus | J Immunol., 2012 Dec | Antibody | SM2069AP |
| Secondary Antibody | Absence of glomerular IgG4 deposition in patients with membranous nephropathy may indicate malignancy | Nephrol. Dial. Transplant., 2012 Oct | Antibody | AM01158AP-N |
| Secondary Antibody | Absence of glomerular IgG4 deposition in patients with membranous nephropathy may indicate malignancy | Nephrol. Dial. Transplant., 2012 Oct | Antibody | AM01158HR-N |
| Secondary Antibody | Non-invasive monitoring of immunization progress in mice via IgG from feces | In Vivo, 2012 Jan | Antibody | R1256AP |
| Secondary Antibody | Non-invasive monitoring of immunization progress in mice via IgG from feces | In Vivo, 2012 Jan | Antibody | R1256B |
| Secondary Antibody | Non-invasive monitoring of immunization progress in mice via IgG from feces | In Vivo, 2012 Jan | Antibody | R1256F |
| Secondary Antibody | Non-invasive monitoring of immunization progress in mice via IgG from feces | In Vivo, 2012 Jan | Antibody | R1256HRP |
| Secondary Antibody | Non-invasive monitoring of immunization progress in mice via IgG from feces | In Vivo, 2012 Jan | Antibody | R1256T |
Germany
Japan
United Kingdom
China